Erika Check Hayden is an award-winning, San Francisco-based science and technology reporter. She writes for Nature, and on a freelance basis for a variety of publications, and is a lecturer in the University of California, Santa Cruz Science Communication Program.
Erika Check Hayden
Freelance writer
From this contributor
For studies, size matters: Let us count the ways
In autism research, as in other fields, small sample sizes can lead to false findings. The size of the sample needed for statistical significance depends on the type of study.
For studies, size matters: Let us count the ways
Preprint server bioRxiv gets boost from Facebook billionaire
The Chan Zuckerberg Initiative has pledged to provide financial support for bioRxiv, a website where researchers can share manuscripts before peer review.
Preprint server bioRxiv gets boost from Facebook billionaire
Book review: ‘Rigor Mortis’ reveals rampant sloppiness in science
In his new book, journalist Richard Harris writes that lack of reproducibility in research poses a serious threat to science.
Book review: ‘Rigor Mortis’ reveals rampant sloppiness in science
Rising star: Somer Bishop fine-tunes autism diagnosis
Somer Bishop is launching a revolution in autism diagnosis, creating faster, more precise tools that speed research and better capture the full spectrum of autism symptoms.
Rising star: Somer Bishop fine-tunes autism diagnosis
Explore more from The Transmitter
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.